Skip to main content

Animations

MJFF Publications

7631 - 7640 of 8819 Results
Title
Year
  • Year
  • 2018
  • 2019
  • 2018
  • 2019
  • 2019
  • 2019
  • 2018
  • 2019
  • 2018
  • 2019
  • Summary Details
    OPEN
    Title: A comprehensive screening of copy number variability in dementia with Lewy bodies
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Multimodal MRI evaluation of parkinsonian limbic pathologies
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.01.004
    Citation Count: 14
  • Summary Details
    OPEN
    Title: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104525
    Citation Count: 82
  • Summary Details
    OPEN
    Title: β-catenin aggregation in models of ALS motor neurons: GSK3β inhibition effect and neuronal differentiation
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104497
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: Activation of mGlu2/3 receptors, a novel therapeutic approach to alleviate dyskinesia and psychosis in experimental parkinsonism
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.107725
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.10.013
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Characterization of the Basic Membrane Properties of Neurons of the Rat Dorsal Motor Nucleus of the Vagus in Paraquat-Induced Models of Parkinsonism
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2019.08.048
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.